Main menu

Multi-omic profiling reveals epigenetic drivers of immunotherapy resistance in multiple myeloma

Get startedSubscribe
Return to Resources
Authors: Larissa Haertle, Natalia Buenache Cuenda, Francisco J. Villena González, Isabel Espejo Díaz, Paula Lazaro del Campo, Juan Manuel Rosa-Rosa, Rafael Alberto Alonso Fernandez, Maria Nieves Lopez Muñoz, José María Sánchez-Pina, Almudena García-Ortiz, Antonio Valeri, Santiago Barrio, Fátima Al-Shahrour, Florian Bassermann, Joaquín Martinez-Lopez, Tomás Di Domenico
Read the full text
  • Published on: April 19 2025
  • Source: medRxiv

Getting started

Buy a MinION starter pack Nanopore store Sequencing service providers Channel partners

Quick links

Intellectual property Cookie policy Corporate reporting Privacy policy Terms & conditions Accessibility

About Oxford Nanopore

Contact us News Media resources & contacts Investor centre Careers BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust

© 2008 - 2025 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.

ONT plc is a member of the producer compliance scheme run by ERP UK Ltd, who manage the submission of documentation in support of WEEE compliance for ONT plc’s manufacture and supply of Electrical and Electronic equipment in the UK.

ONT’s WEEE PRN is WEE/MM3828AA. See attached certificate for the submission period 2022.

English flag